Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2223 Views
-
Last post by frodo
-
- 0 Replies
- 10196 Views
-
Last post by NHE
-
- 2 Replies
- 1656 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1854 Views
-
Last post by Petr75
-
- 0 Replies
- 1236 Views
-
Last post by NHE
-
- 2 Replies
- 1888 Views
-
Last post by frodo
-
- 0 Replies
- 10963 Views
-
Last post by NHE
-
- 0 Replies
- 2550 Views
-
Last post by frodo
-
- 0 Replies
- 2704 Views
-
Last post by NHE